InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Alenson Carman. Officer active across 2 companies, notably AGIOS PHARMACEUTICALS, INC.. Cumulatively, 2 filings have been published. Activity tracked since 21 June 2021. The latest transaction was disclosed on 21 June 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations